Antibacterial prophylaxis for neutropenic and high-risk hematology patients-Do the benefits outweigh the risk?

Affiliations

• ¹ Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
• ² Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
• ³ National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
• ⁴ Department of Infectious Diseases and Immunology, Austin Health, Melbourne, Victoria, Australia.
• ⁵ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.